Pacira BioSciences
PCRX72
$14.35arrow_drop_up6.37%$0.86
PCRX72
$14.35
arrow_drop_up6.37%| Key Stats | |
|---|---|
| Open | $13.14 |
| Prev. Close | $13.11 |
| EPS | 1.34 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 13.04 | 13.90 |
| 52 Week Range | 11.16 | 35.95 |
| Ratios | |
|---|---|
| Revenue | - |
| EPS | 1.34 |
| Fundamentals | |
|---|---|
| Payout Ratio | - |
| Industry average yield | 2.90% |
| Last Dividend pay date | - |
| Dividend per share | - |
| Dividend yield forecast | - |
Stock Analysis
Technicals
Summarizing what the indicators are suggesting.
—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell
Analyst rating
An aggregate view of professional's ratings.
—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell
Stock Performance
PCRX-
US Healthcare Sector-
US Market-
check_circle
PCRX / Market
PCRX exceeded the US Market which returned -0.10% over the last twenty four hours.check_circle
PCRX / Healthcare Sector
PCRX exceeded the US Healthcare sector which returned 0.73% over the last twenty four hours.Pacira BioSciences (PCRX) Statistics
Keep an eye on Pacira BioSciences
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is the EBITDA of Pacira BioSciences (PCRX) stock?
The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Pacira BioSciences (PCRX) is $187.27M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help
How much debt does Pacira BioSciences (PCRX) have?
Pacira BioSciences (PCRX) has a total debt of $648.6M. The net debt, which accounts for cash and cash equivalents against the total debt, is $401.54M.
help
How has Pacira BioSciences (PCRX) stock's performance compared to its sector and the market over the past year?
Over the past year, Pacira BioSciences (PCRX) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 24.45%, Pacira BioSciences has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 63.07%, it has fallen short of the market average. This comparison highlights Pacira BioSciences 's performance relative to both its sector and the overall market over the last year.
help
What is the PE ratio of Pacira BioSciences (PCRX) stock?
The PE (Price to Earnings) ratio of Pacira BioSciences (PCRX) is currently 10.71. This metric is used to evaluate the valuation of a company's stock, comparing its current share price relative to its per-share earnings.
help
What is the EPS of Pacira BioSciences (PCRX) stock?
The Earnings Per Share (EPS) for Pacira BioSciences (PCRX), calculated on a diluted basis, is $1.34. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help
What is the operating margin of Pacira BioSciences (PCRX) stock?
The operating margin for Pacira BioSciences (PCRX) is 17.4%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.